Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia

Completed · Phase 2

Conditions studied: Presbyopia

In brief

A study to evaluate the safety and efficacy of AGN-199201 alone, AGN-190584 alone and concurrent use of AGN-199201 and AGN-190584 in patients with presbyopia (inability to focus for near vision).

Key facts

Study ID

NCT02197806

Run by

Allergan

People needed

65

Starts

2014-07-01

Expected to finish

2014-11-01

Last updated by the study team

2015-12-03

Who can join

Age: 40 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Presbyopia in each eye that impacts daily activities.

You may not qualify if…

• Use of any topical ophthalmic medications, including artificial tears
• Contact lens use in either eye within 14 days or planned use during the study
• History of eye surgery
• Diagnosis of any type of glaucoma or ocular hypertension

Where it is running

• Study site — Newport Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.